The killing effect of BCR and some costimulatory molecules, such as CD40 and CD86, on the surface of B cells in response to external antigen stimulation or enhancement of costimulatory signals of CD4+ T cells in tumours can also be used as markers for clinical prognostic monitoring [28, 89, 90]. Here, CD40 is linked to neoplasm.